ID
Idorsia Ltd
IDRSF · OTC
$6.13 +0.00% (+$0.00)
1M -5.69%
Market Cap CHF 1.28B
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
21 /100
Expensive P/S 6.43x
PEG N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 31.56%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 158.74%
Op. margin 79.80%
FCF margin 65.28%
Quality
8 /100
Poor ROA 68.28%
Asset turnover 0.43x
ROIC 47.82%
Debt
6 /100
High Int. coverage 0.18x
Current ratio 0.58x
Net debt/EBITDA N/A
Stability
26 /100
Unstable Rev. volatility 62.62%
EPS volatility 29.45%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IDRSF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jean-Paul Clozel
Employees
487
Headquarters
Allschwil
Upcoming events
29 OCT
Earnings
Upcoming earnings report